APA (7th ed.) Citation

Iriuchishima, H., Saito, A., Mihara, M., Kanaya, S., Yoshizawa, R., Isoda, A., & Matsumoto, M. (2026). Efficacy and Safety of Anti-CD38 Antibody-Containing Triplet Regimens in Frail Patients with Multiple Myeloma. Cancers, 18(7), 1048. https://doi.org/10.3390/cancers18071048

Chicago Style (17th ed.) Citation

Iriuchishima, Hirono, Akio Saito, Masahiro Mihara, Shuhei Kanaya, Ryo Yoshizawa, Atsushi Isoda, and Morio Matsumoto. "Efficacy and Safety of Anti-CD38 Antibody-Containing Triplet Regimens in Frail Patients with Multiple Myeloma." Cancers 18, no. 7 (2026): 1048. https://doi.org/10.3390/cancers18071048.

MLA (9th ed.) Citation

Iriuchishima, Hirono, et al. "Efficacy and Safety of Anti-CD38 Antibody-Containing Triplet Regimens in Frail Patients with Multiple Myeloma." Cancers, vol. 18, no. 7, 2026, p. 1048, https://doi.org/10.3390/cancers18071048.